Neogen (NEOG) Gross Margin (2010 - 2026)
Neogen's (NEOG) quarterly Gross Margin came in at 46.88% in Q1 2026, down 303.0% year-on-year from 23.09% in Q1 2025, and down 1.27% quarter-over-quarter from 47.48% in Q4 2025.
Neogen (NEOG) Gross Margin (2010 - 2026) Analysis & Trends
Neogen's Gross Margin history runs 17 years deep, the most recent figure standing at 46.88% for Q1 2026.
- On a quarterly basis, Gross Margin fell 303.0% year-over-year to 46.88% in Q1 2026; TTM through Feb 2026 was 45.21%, a 358.0% decrease from a year earlier, with the FY2025 full-year figure at 47.1%, down 309.0% from the prior year.
- Gross Margin eased to 46.88% in Q1 2026 per NEOG's latest filing, from 47.48% in the prior quarter.
- Across five years, Gross Margin topped out at 51.08% in Q1 2024 and bottomed at 41.19% in Q2 2025.
- The 5-year median for Gross Margin is 48.36% (2024), against an average of 48.04%.
- Across the five-year window, Gross Margin soared 470 bps in 2023 and tumbled 673 bps in 2025, its largest moves.
- Year by year, Gross Margin stood at 48.92% in 2022, then increased by 4 bps to 50.85% in 2023, then dropped by 4 bps to 49.01% in 2024, then fell by 3 bps to 47.48% in 2025, then declined by 1 bps to 46.88% in 2026.
- Per Business Quant, the three latest NEOG Gross Margin figures stand at 46.88% (Q1 2026), 47.48% (Q4 2025), and 45.4% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 78.01% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 62.95% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 45.22% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 38.53% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Neogen | 2.09 Bn | 1.93 Bn | 99.00 Mn | 46.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 46.88% |
| Nov 30, 2025 | 47.48% |
| Aug 31, 2025 | 45.40% |
| May 31, 2025 | 41.19% |
| Feb 28, 2025 | 49.91% |
| Nov 30, 2024 | 49.01% |
| Aug 31, 2024 | 48.36% |
| May 31, 2024 | 47.92% |
| Feb 29, 2024 | 51.08% |
| Nov 30, 2023 | 50.85% |
| Aug 31, 2023 | 50.99% |
| May 31, 2023 | 50.94% |
| Feb 28, 2023 | 49.47% |
| Nov 30, 2022 | 48.92% |
| Aug 31, 2022 | 47.05% |
| May 31, 2022 | 46.40% |
| Feb 28, 2022 | 44.77% |
| Nov 30, 2021 | 46.43% |
| Aug 31, 2021 | 46.77% |
| May 31, 2021 | 45.27% |